Ian Clark

Ian Clark

Fortune : 2 M $ au 30/09/2026

65 ans
Health Technology
Commercial Services
Consumer Non-Durables

Profil

Mr. Ian T.
Clark
is a Chairman at BioMarin Pharmaceutical, Inc., an Independent Director at Kyverna Therapeutics, Inc., a Chairman at Olema Pharmaceuticals, Inc., a Lead Independent Director at Guardant Health, Inc., a Chairman at X-Vax Technology, Inc. and a Member at TechNet.
He is on the Board of Directors at Asher Biotherapeutics, Inc., Kyverna Therapeutics, Inc. and Guardant Health, Inc. Mr. Clark was previously employed as an Independent Director by GoodRx Holdings, Inc., a Non-Executive Director by Gyroscope Therapeutics Holdings Plc, an Independent Director by Takeda Pharmaceutical Co., Ltd., an Independent Director by Forty Seven LLC, an Independent Director by Tectonic Therapeutic, Inc., an Independent Director by Kite Pharma, Inc., an Independent Director by Corvus Pharmaceuticals, Inc., an Independent Non-Executive Director by Shire Plc, an Independent Director by Agios Pharmaceuticals, Inc., an Independent Director by TerraVia Holdings, Inc., a Chief Executive Officer & Director by Genentech, Inc., a Chief Marketing Officer & Executive Vice President by Roche Group, a General Manager by Novartis Pharmaceuticals Canada, Inc., a Chief Operating Officer by Novartis Pharmaceuticals UK Ltd., a Vice President-Sales by Aventis SA, a Member by Economic Advisory Council, a Vice President-Sales & Marketing by IVAX LLC, a Vice President-Sales by IVAX Pharmaceuticals, Inc., a Vice President-Sales & Marketing by Sanofi, and a Member-BioFulcrum Board by The J.
David Gladstone Institutes.
He also served on the board at Shire Pharmaceuticals, Inc., Dendreon Corp., Dendreon Pharmaceuticals LLC, Biotechnology Innovation Organization, Gladstone Foundation (CA), Ligand UK Ltd., Solazyme, Inc., The Bioindustry Association, Vernalis (R&D) Ltd. and Vernalis Therapeutics, Inc. He received his undergraduate degree from The University of Southampton.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
02/06/2026 14 490 ( 0,01% ) 869 400 $ 30/09/2026
18/03/2026 19 396 ( 0% ) 713 456 $ 30/09/2026
04/08/2026 2 975 ( 0% ) 530 621 $ 30/09/2026
27/05/2026 21 727 ( 0,04% ) 147 744 $ 30/09/2026
20/04/2026 43 100 ( 0,04% ) 141 799 $ 30/09/2026
18/06/2026 0 ( -.--% ) - $ 30/09/2026
11/06/2026 0 ( -.--% ) - $ 30/09/2026

Postes actifs de Ian Clark

SociétésPosteDébut
GUARDANT HEALTH, INC. Directeur/Membre du Conseil 01/12/2016
OLEMA PHARMACEUTICALS, INC. Président 01/08/2020
KYVERNA THERAPEUTICS, INC. Directeur/Membre du Conseil 12/01/2026
BIOMARIN PHARMACEUTICAL INC. Président 02/06/2026
Président -
Directeur/Membre du Conseil 14/02/2022
Corporate Officer/Principal -

Anciens postes connus de Ian Clark

SociétésPosteFin
CORVUS PHARMACEUTICALS, INC. Directeur/Membre du Conseil 22/07/2026
TAKEDA PHARMACEUTICAL COMPANY LIMITED Directeur/Membre du Conseil 24/06/2026
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Ian Clark

Formation de Ian Clark

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

82

Relations au 1er degré

38

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées38

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Solazyme, Inc.

Economic Advisory Council